newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.
biotech/news//STAT
The White House has drafted legislative text for its drug pricing policy.
The White House has drafted legislative text for its drug pricing policy.
KEY POINTS
Officials are sharing this draft with more than a dozen major pharmaceutical companies.
The draft closely follows previous voluntary deals with pharma companies.
The policy would allow cash-purchased drugs to count toward a patient's deductible.
WASHINGTON — The White House has drafted legislative text for its drug pricing policy, and officials are in the process of sharing it with more than a dozen major pharmaceutical companies, according to people familiar with the meetings.
The legislative text, according to a White House official, closely follows the outlines of the voluntary deals the administration made with pharma companies. The draft includes a policy that would allow drugs purchased in cash to count toward a patient’s deductible.
Advertisement